Opyl Limited advised that Dr. Julian Chick has resigned as a Non-Executive Director of the Company, effective immediately as part of a planned transition due to his growing external business commitments. Dr. Chick's efforts over the past few years and his contributions to the growth of the business is much appreciated.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 AUD | 0.00% | +36.84% | -7.14% |
Jun. 06 | Opyl Secures First TrialGen Contract with Brain Vector | MT |
Apr. 29 | Opyl Expands TrialKey Coverage; Shares Up 38% | MT |
1st Jan change | Capi. | |
---|---|---|
-7.14% | 2.93M | |
-3.91% | 29.9B | |
+34.07% | 8.68B | |
+37.91% | 4.56B | |
-28.19% | 2.72B | |
-8.96% | 1.61B | |
-22.22% | 1.34B | |
-37.12% | 1.08B | |
+3.82% | 929M | |
-43.36% | 791M |
- Stock Market
- Equities
- OPL Stock
- News Opyl Limited
- Opyl Limited Announces Resignation of Julian Chick as Non-Executive Director